Margetuximab Expanded Access Program
Clinical trial NCT03133988 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03133988
- Sponsor
- TerSera Therapeutics LLC
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.